Enicuela, Patricia .

HRN: 25-85-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2024
CEFTAZIDIME 1GM (VIAL)
09/12/2024
09/19/2024
IV
2 Grams
Q 8hrs
Ptb
Waiting Final Action 
09/12/2024
AZITHROMYCIN 500MG TABLET (TAB)
09/12/2024
09/16/2024
ORAL
500mg
OD
Ptb
Waiting Final Action 
09/12/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/12/2024
09/19/2024
IV
4.5 Grams
Q8H
PTB
Waiting Final Action 
09/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/14/2024
09/27/2024
IVT
4.5g
Q6H
Acute Respiratory Failure Sec To COPD In AE; T/c PTB Treatment Failure
Waiting Final Action 
09/19/2024
MUPIROCIN 2%, 15G (TUBE)
09/19/2024
09/26/2024
TOPICAL
2%
BID
Decubitus Ulcer
Waiting Final Action 
09/28/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/28/2024
10/04/2024
IV
750
Od
Pneumonia
Waiting Final Action 
10/05/2024
MUPIROCIN 2%, 15G (TUBE)
10/05/2024
10/12/2024
TOPICAL
As Needed
BID
Sacral Ulcer
Waiting Final Action 
10/07/2024
CEFTAZIDIME 1GM (VIAL)
10/07/2024
10/14/2024
IV
2grams
Every 8 Hours
CAP MR
Waiting Final Action 
10/08/2024
LEVOFLOXACIN 500MG (TAB)
10/08/2024
10/14/2024
PER NGT
1 And 1/2 Tab
Cap MR
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: